Cargando…

Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties

A wild-type (wt) p53 gene characterizes thyroid tumors, except for the rare anaplastic histotype. Because p53 inactivation is a prerequisite for tumor development, alterations of p53 regulators represent an alternative way to impair p53 function. Indeed, murine double minute 2 (MDM2), the main p53 n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prodosmo, Andrea, Giglio, Simona, Moretti, Sonia, Mancini, Francesca, Barbi, Flavia, Avenia, Nicola, Di Conza, Giusy, Schünemann, Holger J., Pistola, Lorenza, Ludovini, Vienna, Sacchi, Ada, Pontecorvi, Alfredo, Puxeddu, Efisio, Moretti, Fabiola
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2008
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359832/ https://www.ncbi.nlm.nih.gov/pubmed/18335186 http://dx.doi.org/10.1007/s00109-008-0322-6

Ejemplares similares

Intracellular Signal Transduction and Modification of the Tumor Microenvironment Induced by RET/PTCs in Papillary Thyroid Carcinoma
por: Menicali, Elisa, et al.
Publicado: (2012)

MDM4 (MDMX) and its Transcript Variants
por: Mancini, F, et al.
Publicado: (2009)

MDM4 actively restrains cytoplasmic mTORC1 by sensing nutrient availability
por: Mancini, Francesca, et al.
Publicado: (2017)

Impact of Epithelial–Mesenchymal Immunophenotype on Local Aggressiveness in Papillary Thyroid Carcinoma Invading the Airway
por: Mandarano, Martina, et al.
Publicado: (2021)

Long glucocorticoid-induced leucine zipper regulates human thyroid cancer cell proliferation
por: Ayroldi, Emira, et al.
Publicado: (2018)

A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report
por: Colombo, Mara, et al.
Publicado: (2023)

Corrigendum: A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: a case report
por: Colombo, Mara, et al.
Publicado: (2023)

Immune Landscape of Thyroid Cancers: New Insights
por: Menicali, Elisa, et al.
Publicado: (2021)

MDM2–MDM4 molecular interaction investigated by atomic force spectroscopy and surface plasmon resonance
por: Moscetti, Ilaria, et al.
Publicado: (2016)

Role of Sex in the Therapeutic Targeting of p53 Circuitry
por: Mancini, Francesca, et al.
Publicado: (2021)

Estrogens Counteract Platinum-Chemosensitivity by Modifying the Subcellular Localization of MDM4
por: Lucà, Rossella, et al.
Publicado: (2019)

Methylglyoxal Acts as a Tumor-Promoting Factor in Anaplastic Thyroid Cancer
por: Antognelli, Cinzia, et al.
Publicado: (2019)

RET Rearrangement as a Predictor of Unresponsiveness to Immunotherapy in Non-Small Cell Lung Cancer: Report of Two Cases with Review of the Literature
por: Baglivo, Sara, et al.
Publicado: (2020)

MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response
por: Mancini, F, et al.
Publicado: (2016)

INSL4 as prognostic marker for proliferation and invasiveness in Non-Small-Cell Lung Cancer
por: Scopetti, Damiano, et al.
Publicado: (2021)

Effect of p53 activation through targeting MDM2/MDM4 heterodimer on T regulatory and effector cells in the peripheral blood of Type 1 diabetes patients
por: Pellegrino, Marsha, et al.
Publicado: (2020)

Prevalence and Spectrum of BRCA Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study
por: Foglietta, Jennifer, et al.
Publicado: (2020)

The Aryl Hydrocarbon Receptor Is Expressed in Thyroid Carcinoma and Appears to Mediate Epithelial-Mesenchymal-Transition
por: Moretti, Sonia, et al.
Publicado: (2020)

Maternal thyroid hormones are transcriptionally active during embryo–foetal development: results from a novel transgenic mouse model
por: Nucera, Carmelo, et al.
Publicado: (2010)

Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy
por: Ludovini, Vienna, et al.
Publicado: (2017)

Turning a Tumor Microenvironment Pitfall into Opportunity: Discovery of Benzamidoxime as PD-L1 Ligand with pH-Dependent Potency
por: Bianconi, Elisa, et al.
Publicado: (2023)

Case Report: Papillary thyroid carcinoma in Goltz–Gorlin syndrome
por: Costanza, Flavia, et al.
Publicado: (2023)

What Is New in Thyroid Cancer: The Special Issue of the Journal Cancers
por: Puxeddu, Efisio, et al.
Publicado: (2020)

Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with Immunotherapy
por: Baglivo, Sara, et al.
Publicado: (2021)

Inhibition of the mTOR pathway and reprogramming of protein synthesis by MDM4 reduce ovarian cancer metastatic properties
por: Lucà, Rossella, et al.
Publicado: (2021)

Editorial: Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Clinical and Genetic Update
por: Valerio, Laura, et al.
Publicado: (2022)

ER Stress Responses: An Emerging Modulator for Innate Immunity
por: Di Conza, Giusy, et al.
Publicado: (2020)

The mTOR and PP2A Pathways Regulate PHD2 Phosphorylation to Fine-Tune HIF1α Levels and Colorectal Cancer Cell Survival under Hypoxia
por: Di Conza, Giusy, et al.
Publicado: (2017)

Clinical Outcome, Role of BRAF(V600E), and Molecular Pathways in Papillary Thyroid Microcarcinoma: Is It an Indolent Cancer or an Early Stage of Papillary Thyroid Cancer?
por: Nucera, Carmelo, et al.
Publicado: (2012)

Long-term efficacy and safety of fourth-line multikinase inhibitor treatment with lenvatinib in a young papillary thyroid carcinoma patient
por: Morelli, S., et al.
Publicado: (2017)

Anatomy of Mdm2 and Mdm4 in evolution
por: Tan, Ban Xiong, et al.
Publicado: (2017)

Unusual metastasis of papillary renal cell carcinoma to the pyriform sinus: Case report
por: Gioia, Edoardo, et al.
Publicado: (2019)

Mouse models of Mdm2 and Mdm4 and their clinical implications
por: Xiong, Shunbin
Publicado: (2013)

Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
por: Mrkvová, Zuzana, et al.
Publicado: (2019)

Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
por: Huun, Johanna, et al.
Publicado: (2017)

Unique case of sporadic multiple gastro intestinal stromal tumour
por: Graziosi, Luigina, et al.
Publicado: (2015)

Erratum to: ‘Conditional robustness analysis for fragility discovery and target identification in biochemical networks and in cancer systems biology’
por: Bianconi, Fortunato, et al.
Publicado: (2016)

OR21-07 The 2015 American Thyroid Association Risk Stratification System Is a Predictor of Persistent Disease in Real-World Clinical Practice
por: Grani, Giorgio, et al.
Publicado: (2020)

The role of MDM2 and MDM4 in breast cancer development and prevention
por: Haupt, Sue, et al.
Publicado: (2017)

AUCO ResNet: an end-to-end network for Covid-19 pre-screening from cough and breath
por: Dentamaro, Vincenzo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mh2qs6gcpt4ilefmn3n0b46j8d